Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/127027
dc.contributor.author | Ruiz de Garibay, Gorka |
---|---|
dc.contributor.author | Mateo, Francesca |
dc.contributor.author | Stradella, Agostina |
dc.contributor.author | Valdés Mas, Rafael |
dc.contributor.author | Palomero, Luis |
dc.contributor.author | Serra-Musach, Jordi |
dc.contributor.author | Puente, Diana A. |
dc.contributor.author | Díaz-Navarro, Ander |
dc.contributor.author | Vargas Parra, Gardenía María |
dc.contributor.author | Tornero, Eva |
dc.contributor.author | Morilla, Idoia |
dc.contributor.author | Farré, Lourdes |
dc.contributor.author | Martinez-Iniesta, María |
dc.contributor.author | Herranz, Carmen |
dc.contributor.author | McCormack, Emmet |
dc.contributor.author | Vidal-Bel, August |
dc.contributor.author | Petit, Anna |
dc.contributor.author | Soler, María Teresa |
dc.contributor.author | Lázaro García, Conxi |
dc.contributor.author | Puente, Xose S. |
dc.contributor.author | Villanueva Garatachea, Alberto |
dc.contributor.author | Pujana Genestar, M. Ángel |
dc.date | 2018-12-18T11:37:27Z |
dc.date | 2018-12-18T11:37:27Z |
dc.date | 2018-05-18 |
dc.date | 2018-12-18T11:37:27Z |
dc.identifier.citation | 1754-8403 |
dc.identifier.citation | 681230 |
dc.identifier.uri | http://hdl.handle.net/2445/127027 |
dc.format | 10 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | The Company of Biologists |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1242/dmm.032292 |
dc.relation | Disease Models & Mechanisms, 2018, vol. 11, num. 5, p. dmm032292 |
dc.relation | https://doi.org/10.1242/dmm.032292 |
dc.rights | cc-by (c) Ruiz de Garibay, Gorka et al., 2018 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Càncer de mama |
dc.subject | Quimioteràpia del càncer |
dc.subject | Factors de transcripció |
dc.subject | Resistència als medicaments |
dc.subject | Cribratge |
dc.subject | Breast cancer |
dc.subject | Cancer chemotherapy |
dc.subject | Transcription factors |
dc.subject | Drug resistance |
dc.subject | Medical screening |
dc.title | Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |